Surfactant protein D binding to Aspergillus fumigatus hyphae is calcineurin-sensitive.
Surfactant protein D (SP-D) plays a central role in pulmonary innate immune responses to microbes and allergens, often enhancing clearance of inhaled material. Although SP-D functions during bacterial and viral infections are well established, much less is known about its possible roles during invasive fungal infections. Aspergillus fumigatus is a prominent fungal pathogen in immunocompromised individuals, and can cause allergic or invasive aspergillosis. SP-D has been shown to be protective against both of these disease modalities. The moieties present on the fungal surface responsible for SP-D binding remain largely unclear, although cell wall 1,3-beta-D-glucan is bound by SP-D in other fungal species. There is little information regarding the interaction of SP-D with A. fumigatus hyphae which are responsible for the invasive form of disease. Here, we show that SP-D binding to A. fumigatus hyphae is sensitive to the activity of the calcium-activated protein phosphatase calcineurin. Deletion of the catalytic subunit calcineurin A (DeltacnaA) or pharmacologic inhibition of calcineurin through FK506 abrogated SP-D binding. In contrast, SP-D binding to Cruptococcus neoformans was calcineurin-independent. Pharmacologic inhibition of A. fumigatus cell wall components by caspofungin (inhibits 1,3-beta-D-glucan synthesis) and nikkomycin Z (inhibits chitin synthesis) increased SP-D binding to the wild-type strain. In contrast, SP-D binding increased in the DeltacnaA strain only after nikkomycin Z treatment. We conclude that SP-D binding to A. fumigatus hyphae is calcineurin-sensitive, presumably as a consequence of calcineurin's role in regulating production of key cell wall binding partners, such as 1,3-beta-D-glucan. Elucidation of the interaction between lung innate immune factors and A. fumigatus could lead to the development of novel therapeutic interventions.
Department of Cell Biology, Duke University Medical Center, Durham, North Carolina 27710, USA.
Scarlett
S
Geunes-Boyer
Joseph
J
Heitman
Jo Rae
JR
Wright
William J
WJ
Steinbach
D000617:Aminoglycosides / Q000494:pharmacology; D000818:Animals; D001228:Aspergillosis / Q000276:immunology / Q000382:microbiology; D001232:Aspergillus fumigatus / Q000378:metabolism*; D016466:CHO Cells; D019703:Calcineurin / Q000378:metabolism*; D006224:Cricetinae; D003412:Cricetulus; D003455:Cryptococcus neoformans / Q000378:metabolism; D005434:Flow Cytometry; D006801:Humans; D025301:Hyphae / Q000378:metabolism*; D008168:Lung / Q000276:immunology / Q000382:microbiology; D037663:Pulmonary Surfactant-Associated Protein D / Q000378:metabolism*; D016559:Tacrolimus / Q000494:pharmacology
D000617:Aminoglycosides; D037663:Pulmonary Surfactant-Associated Protein D; C011952:nikkomycin; D019703:Calcineurin; D016559:Tacrolimus